This article has Open Peer Review reports available.
A case of myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis and concurrent membranous nephropathy
© Shimada et al.; licensee BioMed Central Ltd. 2013
Received: 13 August 2012
Accepted: 12 March 2013
Published: 28 March 2013
Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (MPO-ANCA-GN) and concurrent membranous nephropathy (MN) are very rare combination. Their causal relationship has been suggested, but not determined.
A 73-years-old male with 5-year history of proteinuria underwent an operation for his sigmoid colon cancer. Seven months later, he was referred to a nephrology division due to an exacerbating renal function and hypoalbuminemia. Laboratory examination revealed positive MPO-ANCA in the serum. A renal biopsy revealed a necrotizing extracapillary proliferative glomerulonephritis with crescents, demonstrating MPO-ANCA-GN. Whereas, immunofluorescent staining documented granular deposition of immumoglobulin (Ig) G and C3 along the capillary wall and electron microscopy showed subepithelial deposits in the glomerular basement membrane demonstrating MN. Immunofluorescent staining of IgG subclass showed positive IgG1, IgG2, negative IgG3 and weak positive IgG4 suggested the possibility of malignancy-associated MN.
Combination of MPO-ANCA-GN and MN are rare. Although the causal relationship has been suggested in some cases, we should consider all the possibilities including idiopathic MN and secondary MN associated with malignancy, drug use or infection.
Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) is usually characterized by necrotizing and crescentic glomerulonephritis without the deposition of immunoglobulin and complement, therefore, it is called pauci immune type. Whereas, immunoglobulin depositions have been sometimes observed  and very rare cases of membranous nephropathy (MN) and the concurrent ANCA-GN and have been suggested [2–6]. The precise mechanism of the combination of these two etiologies is not clear due to the limited numbers of the patients. Here we describe a case of myeloperoxidase (MPO)-ANCA-GN complicated with MN developed in 73-years-old male.
3 week pulse therapy with methylprednisolone (500 mg for 3 days/week) followed by oral prednisolone (30 mg/day) decreased the levels of serum MPO-ANCA to normal range. Microhematuria was disappeared and CRP became negative, however, the levels of proteinuria and renal function did not improve. In a month, the antigenemia of the cytomegalovirus became positive without any clinical symptoms and was treated with valganciclovir. Therefore, prednisolone was tapered without adding immunosuppressants. Hemodialysis was initiated 6 months after the diagnosis of MPO-ANCA-GN. There was no recurrence of colon cancer and MPO-ANCA remained negative during the follow-up.
MN and concurrent MPO-ANCA-GN are very rare combination. It has been a question whether this is just a coincidence or there is a causal relationship. Recently, Hamamura et al. showed that MPO-ANCA-GN may cause MN-like lesions by demonstrating partial co-localization of MPO and IgG within the electron dense deposits . There are also several characteristics observed in concurrent MN and ANCA-GN. Granular deposition of IgG and C3 along the GBM is similar, but IgG subclass deposition is different from predominant IgG4 pattern in idiopathic-MN and IgG1 and IgG4 depesition is reported in several cases [6, 7]. This is compatible with the fact that the serum subclass of MPO-ANCA consisted mainly of IgG1 and IgG4 . Besides, the electron microscopy findings show irregular dense deposits different from the global pattern of the idiopathic-MN. Due to the small numbers of the cases, further investigation is necessary for further understanding of the relationship between these two etiologies. In most cases, these two etiologies found concurrently, therefore, causal relationship is quite probable [2, 5, 7]. On the other hand, this may not explain all the cases, especially when MN and ANCA-GN diagnosed at different time course. In some cases, MPO-ANCA-GN was found during the remission of the MN [3, 5]. These cases may be truly coincidental occurrence of the idiopathic-MN and MPO-ANCA-GN. Additionally, other causes such as malignancy-associated, infection-associated and drug-induced MN should be considered as well. In our case, MN and MPO-ANCA-GN were diagnosed simultaneously, but the long duration of the proteinuria and the colon cancer suggested the possibility of malignancy associated-MN which presumably preceded MPO-ANCA-GN at least to some extent. Electron microscopy findings also showed dense deposits of stage 3, relatively old lesion of MN. Additionally, predominant IgG1 and IgG2 deposition also suggested that MN in our case was secondary MN due to malignancy . However, since we could not see the obvious improvement of proteinuria after the surgery of the colon cancer, we could not definitively diagnose that this case was malignancy associated-MN. Thus, concurrent MN and MPO-ANCA-GN possibly include different etiologies. Precise observation of these cases, especially the onset of the diseases, the analysis of IgG subclass in the glomerular deposition and the examination for the existence of the anti M-type phospholipase A2 receptor antibody which is demonstrated as the cause of idiopatic-MN also would help further understanding of these cases .
Causal relationship has been suggested in the combination of MPO-ANCA-GN and MN in some cases, however, we should consider all the possibilities including malignancy, drug or infection associated MN as well as idiopathic MN. Besides, the analysis of the IgG subclass in the glomerular deposition may be of help.
Written informed consent was obtained from the patient for publication of the study in the BMC Nephrology.
- Haas M, Eustace JA: Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int. 2004, 65 (6): 2145-2152. 10.1111/j.1523-1755.2004.00632.x.View ArticlePubMedGoogle Scholar
- Nasr SH, Said SM, Valeri AM, Stokes MB, Masani NN, D’Agati VD, Markowitz GS: Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol. 2009, 4 (2): 299-308. 10.2215/CJN.04060808.View ArticlePubMedPubMed CentralGoogle Scholar
- Kanahara K, Yorioka N, Nakamura C, Kyuden Y, Ogata S, Taguchi T, Yamakido M: Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis with membranous nephropathy in remission. Intern Med. 1997, 36 (11): 841-846. 10.2169/internalmedicine.36.841.View ArticlePubMedGoogle Scholar
- Dwyer KM, Agar JW, Hill PA, Murphy BF: Membranous nephropathy and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: a report of 2 cases. Clin Nephrol. 2001, 56 (5): 394-397.PubMedGoogle Scholar
- Tse WY, Howie AJ, Adu D, Savage CO, Richards NT, Wheeler DC, Michael J: Association of vasculitic glomerulonephritis with membranous nephropathy: a report of 10 cases. Nephrol Dial Transplant. 1997, 12 (5): 1017-1027. 10.1093/ndt/12.5.1017.View ArticlePubMedGoogle Scholar
- Suwabe T, Ubara Y, Tagami T, Sawa N, Hoshino J, Katori H, Takemoto F, Hara S, Aita K, Hara S: Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis. Intern Med. 2005, 44 (8): 853-858. 10.2169/internalmedicine.44.853.View ArticlePubMedGoogle Scholar
- Hanamura K, Tojo A, Kinugasa S, Asaba K, Onozato ML, Uozaki H, Fukayama M, Fujita T: Detection of myeloperoxidase in membranous nephropathy-like deposits in patients with anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. Hum Pathol. 2011, 42 (5): 649-658. 10.1016/j.humpath.2010.08.020.View ArticlePubMedGoogle Scholar
- Segelmark M, Wieslander J: IgG subclasses of antineutrophil cytoplasm autoantibodies (ANCA). Nephrol Dial Transplant. 1993, 8 (8): 696-702.PubMedGoogle Scholar
- Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004, 19 (3): 574-579. 10.1093/ndt/gfg616.View ArticlePubMedGoogle Scholar
- Beck LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. New Engl J Med. 2009, 361 (1): 11-21. 10.1056/NEJMoa0810457.View ArticlePubMedPubMed CentralGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/14/73/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.